Concepedia

Effect of CYP2D6 genetic polymorphism on the metabolism of citalopram in vitro

Xiaoxia Hu, Lingjing Yuan, Ping Fang, Yonghui Mao, Yunyun Zhan, Xiangyü Li, Da‐Peng Dai, Jian‐Ping Cai, Guoxin Hu

Drug Metabolism and Pharmacokinetics · 2016 · 15 citations · 17 references

DOI

Concepts

References

17

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance

Shufeng Zhou · Clinical Pharmacokinetics · 2009 · 759 citations

, , +14

Nomenclature for human CYP2D6 alleles

Ann K. Daly, Jürgen Brockmöller, Franck Broly et al. · Pharmacogenetics · 1996 · 400 citations

, , +13

Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram.

Lisa L. von Moltke, David J. Greenblatt, Gina M. Giancarlo et al. · PubMed · 2001 · 200 citations

, , +17

Citalopram--a review of pharmacological and clinical effects.

Kalyna Z. Bezchlibnyk-Butler, Ivana Aleksić, Sidney H. Kennedy · PubMed · 2000 · 176 citations

, , +17

Comparative Metabolic Capabilities and Inhibitory Profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17

Hongwu Shen, Minxia M. He, Houfu Liu et al. · Drug Metabolism and Disposition · 2007 · 161 citations

, , +17